These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 786368)

  • 1. Reductive microbial conversion of anthracycline antibiotics.
    Marshall VP; Reisender EA; Reineke LM; Johnson JH; Wiley PF
    Biochemistry; 1976 Sep; 15(19):4139-45. PubMed ID: 786368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial metabolism of anthracycline antibiotics. Steffimycinone and steffimycinol conversions.
    Wiley PF; Koert JM; Elrod DW; Reisender EA; Marshall VP
    J Antibiot (Tokyo); 1977 Aug; 30(8):649-54. PubMed ID: 20436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbial conversion of anthracycline antibiotics.
    Wiley PF; Marshall VP
    J Antibiot (Tokyo); 1975 Oct; 28(10):838-40. PubMed ID: 1102512
    [No Abstract]   [Full Text] [Related]  

  • 4. Anthracycline antibiotic reduction by spinach ferredoxin-NADP+ reductase and ferredoxin.
    Fisher J; Abdella BR; McLane KE
    Biochemistry; 1985 Jul; 24(14):3562-71. PubMed ID: 3862429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of dissociation of nogalamycin from DNA: comparison with other anthracycline antibiotics.
    Fox KR; Brassett C; Waring MJ
    Biochim Biophys Acta; 1985 Jul; 840(3):383-92. PubMed ID: 3859336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammalian and microbial cell-free conversion of anthracycline antibiotics and analogs.
    Rueckert PW; Wiley PF; McGovren JP; Marshall VP
    J Antibiot (Tokyo); 1979 Feb; 32(2):141-7. PubMed ID: 35508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbial conversion of steffimycin and steffimycin B to 10-dihydrosteffimycin and 10-dihydrosteffimycin B.
    Wiley PF; Elrod DW; Slavicek JM; Marshall VP
    J Antibiot (Tokyo); 1980 Aug; 33(8):819-23. PubMed ID: 7429984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsomal reductive glycosidase.
    Bachur NR; Gee M
    J Pharmacol Exp Ther; 1976 Jun; 197(3):681-6. PubMed ID: 6790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of fluorescence by anthracycline antibiotics: effects of xanthine oxidase and identification of the nonfluorescent metabolites.
    Dodion P; Bernstein AL; Fox BM; Bachur NR
    Cancer Res; 1987 Feb; 47(4):1036-9. PubMed ID: 3467841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial metabolism of anthracycline antibiotics daunomycin and adriamycin.
    Marshall VP; McGovren JP; Richard FA; Richard RE; Wiley PF
    J Antibiot (Tokyo); 1978 Apr; 31(4):336-42. PubMed ID: 26650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anthracycline antibiotic pharmacology and metabolism.
    Bachur NR
    Cancer Treat Rep; 1979 May; 63(5):817-20. PubMed ID: 455323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biotransformations of daunorubicin aglycones by rat liver microsomes.
    Schwartz HS; Paul B
    Cancer Res; 1984 Jun; 44(6):2480-4. PubMed ID: 6722790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosynthesis of daunorubicin glycosides: role of epsilon-rhodomycinone.
    McGuire JC; Thomas MC; Stroshane RM; Hamilton BK; White RJ
    Antimicrob Agents Chemother; 1980 Sep; 18(3):454-64. PubMed ID: 7425613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbial conversion of anthracycline antibiotics. I. Microbial conversion of aclacinomycin B to aclacinomycin A.
    Hoshino T; Sekine Y; Fujiwara A
    J Antibiot (Tokyo); 1983 Nov; 36(11):1458-62. PubMed ID: 6581152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbial conversion of anthracycline antibiotics. IV. Study on the glycosidation of epsilon-pyrromycinone by Streptomyces galilaeus OBB-111-848.
    Hoshino T; Fujiwara A
    J Antibiot (Tokyo); 1984 Nov; 37(11):1473-4. PubMed ID: 6511669
    [No Abstract]   [Full Text] [Related]  

  • 16. Laser flow cytometric studies on the intracellular fluorescence of anthracyclines.
    Krishan A; Ganapathi R
    Cancer Res; 1980 Nov; 40(11):3895-900. PubMed ID: 6937236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbial conversion of anthracycline antibiotics. II. Characterization of the microbial conversion products of auramycinone by Streptomyces coeruleorubidus ATCC 31276.
    Hoshino T; Fujiwara A
    J Antibiot (Tokyo); 1983 Nov; 36(11):1463-7. PubMed ID: 6654755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial purification and characterization of a bacterial enzyme catalyzing reductive cleavage of anthracycline glycosides.
    McCarville M
    Biochem Biophys Res Commun; 1977 Jan; 74(2):331-5. PubMed ID: 13796
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolism of the anthracycline antibiotic daunorubicin to daunorubicinol and deoxydaunorubicinol aglycone in hepatocytes isolated from the rat and the rabbit.
    Gewirtz DA; Yanovich S
    Biochem Pharmacol; 1986 Nov; 35(22):4059-64. PubMed ID: 3778526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complexation of anthracycline antibiotics by the apo egg white riboflavin binding protein.
    Fisher J; Ramakrishnan K; McLane KE
    Biochemistry; 1982 Nov; 21(24):6172-80. PubMed ID: 6960926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.